Amyotrophic lateral sclerosis (ALS)
is a neurological disease and also termed as Lou Gehrig’s disease which results in a specific disorder that involves the death of neurons that control voluntary muscles. This is a fast progressing, invariably fatal neurological disease that attacks and damages the nerve cells (neurons) which responsible for controlling voluntary muscles. This disease is classified amongst group of disorders known as motor neuron diseases which involves gradual degeneration and death of motor neurons located in the brain, brain stem, and spinal cord. Motor Neurons acts as controlling units and vital communication links between the nervous system and the voluntary muscles of the body. Initial symptoms of this disease include fasciculation, cramps, tight and stiff muscles, muscle weakness affecting an arm or a leg, slurred and nasal speech, or difficulty chewing or swallowing which are generally overlooked or ignored.
This report identifies the global Amyotrophic lateral sclerosis market
size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global Amyotrophic lateral sclerosis market.
Globally, North America contributed the highest revenues in Amyotrophic lateral sclerosis market due high number of reported instances and deep reach of the treatments to the large number of population followed by Europe and Asia-Pacific regions as the second and third largest markets for Amyotrophic lateral sclerosis. Developing medical infrastructure in the emerging economies is expected to drive the growth of Amyotrophic lateral sclerosis market in these economies in the near future.In this report global Amyotrophic lateral sclerosis market is further segmented based on the basis of drug type, treatment type and distribution channel partners and geography type as follows:
This report identifies all the major companies operating in the global Amyotrophic lateral sclerosis market. Some of the major companies’ profiles in detail are as follows:
- Global Amyotrophic Lateral Sclerosis Market, By Drug Type (2014-2021): Riluzole, and Nuedexta
- Global Amyotrophic Lateral Sclerosis Market, By Treatment Type (2014-2021): Stem Cell Therapy, and Chemotherapy
- Global Amyotrophic Lateral Sclerosis Market, By Distribution Partners(2014-2021): Hospitals, Diagnostic centres, Clinics, and Retail Pharmacies
- This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
- GNT Pharma
- Synthetic Biologics
- Avicena inc
- Amkor Pharma
- Mitsubishi Tanabe Pharma